ASX Other Income/Expenses (Net)

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing Two Common Shares) · Other Income/Expenses (Net)

ASX logo

ASX Other Income/Expenses (Net)

Latest reported$4.57B TWD
ASX Quarterly Other Income/Expenses (Net) · TWD (-$11.66B → $4.57B)
High-resolution chart · PNG

ASX other income/expenses (net) history

Quarterly · TWD. Dates are reporting period ends; fiscal years can differ from calendar years.

ASE Technology Holding Co., Ltd. American Depositary Shares (each representing Two Common Shares) Other Income/Expenses (Net) — Quarterly (TWD)
Period endingOther Income/Expenses (Net) (TWD)
4,566,000,000
674,904,000
575,387,000
775,000,000
-1,131,786,000
139,872,000
34,136,000
569,690,000
829,572,000
340,993,000
268,615,000
584,705,000
433,792,000
-102,286,000
155,782,000
-358,527,000
253,348,982
279,575,000
17,366,549,000
-169,932,000
28,107,000
129,944,000
1,199,081,000
-262,527,000
308,665,000
-968,132,000
-266,001,000
-804,645,000
129,104,000
186,903,000
-1,429,426,000
-351,962,000
7,618,929,000
-729,673,309
80,882,000
717,233,000
6,204,840,000
-1,345,238,230
1,129,190,000
-1,008,456,568
191,000,000
168,000,000
-229,000,000
1,428,196,000
-9,000,000
-786,268,000
-267,000,000
491,000,000
-550,000,000
-786,361,000
-484,000,000
-15,000,000
-365,000,000
-443,996,000
-118,000,000
212,000,000
-410,927,000
-242,000,000
-549,090,000
-112,000,000
246,000,000
708,882,000
-500,377,000
-190,000,000
-380,000,000
-273,100,000
10,047,000
-110,000,000
-290,000,000
-235,000,000
-1,487,226,000
-561,000,000
-22,000,000
-69,000,000
-902,409,644
-260,751,920
-295,556,760
-496,458,600
-148,180,392
-562,690,310
3,145,163,890
-585,004,320
-936,755,255
-265,480,880
-9,873,417,840
-283,464,540
-3,266,695,190
-203,735,160
-302,521,050
-230,642,510
-465,673,223
-472,175,340
-311,418,720
-486,111,080
161,578,206
-174,520,050
-166,944,900
-139,958,000
-1,043,485,370
-329,159,600
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.